A. Marijne Heeren - Concepedia

Author

A. Marijne Heeren

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

A Marijne Heeren, A. Heeren, A. M. Heeren, A. Marijne Heeren, A.Marijne Heeren, Anne Marijne Heeren, M Heeren, Marijne Heeren

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Leiden University Medical Center The Netherlands Cancer Institute Cancer Center Amsterdam Centrum voor Gynaecologische Oncologie Amsterdam

About

A. Marijne Heeren is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, pathology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	134
2	Cell Biology	3	3	99
3	Public Health	2	2	35
4	Health Sciences	1	1	40
5	Biology	1	1	17

A. Marijne Heeren

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix A. Marijne Heeren, Simone Punt, Maaike C.G. Bleeker, Modern Pathology	2016	292
High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer A. Marijne Heeren, Bas D. Koster, Sanne Samuels, Cancer Immunology Research	2014	112
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma Sarah R. Ottenhof, Rosa S. Djajadiningrat, Helene Thygesen, Frontiers in Immunology	2018	102
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential Jossie Rotman, Leontine A. S. den Otter, Maaike C.G. Bleeker, Frontiers in Immunology	2020	101
Development of the follicular basement membrane during human gametogenesis and early folliculogenesis A. Marijne Heeren, Liesbeth van Iperen, Daniëlle B. Klootwijk, BMC Developmental Biology	2015	91
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases Debbie M. Ferns, A. Marijne Heeren, Sanne Samuels, Journal for ImmunoTherapy of Cancer	2016	70
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer A. Marijne Heeren, Iske F. van Luijk, Joost Lakeman, Cancer Immunology Immunotherapy	2019	70
Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels A. Marijne Heeren, Jossie Rotman, Anita G.M. Stam, Journal for ImmunoTherapy of Cancer	2019	55
Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area A. Marijne Heeren, Eline de Boer, Maaike C.G. Bleeker, Oncotarget	2015	47
Cancer immunophenotyping by seven‐colour multispectral imaging without tyramide signal amplification Marieke E. Ijsselsteijn, Thomas P. Brouwer, Ziena Abdulrahman, The Journal of Pathology Clinical Research Immunocytochemical TechniqueOncologic ImagingImmunologyImmunoeditingPathology	2018	40

Page 1